Literature DB >> 16284430

Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.

Jaeduk Yoshimura Noh1, Naoko Momotani, Shuji Fukada, Koichi Ito, Akira Miyauchi, Nobuyuki Amino.   

Abstract

The serum T3 to T4 ratio is a useful indicator for differentiating destruction-induced thyrotoxicosis from Graves' thyrotoxicosis. However, the usefulness of the serum free T3 (FT3) to free T4 (FT4) ratio is controversial. We therefore systematically evaluated the usefulness of this ratio, based on measurements made using two widely available commercial kits in two hospitals. Eighty-two untreated patients with thyrotoxicosis (48 patients with Graves' disease and 34 patients with painless thyroiditis) were examined in Kuma Hospital, and 218 patients (126 with Graves' disease and 92 with painless thyroiditis) and 66 normal controls were examined in Ito Hospital. The FT3 and FT4 values, as well as the FT3/FT4 ratios, were significantly higher in the patients with Graves' disease than in those with painless thyroiditis in both hospitals, but considerable overlap between the two disorders was observed. Receiver operating characteristic (ROC) curves for the FT3 and FT4 values and the FT3/FT4 ratios of patients with Graves' disease and those with painless thyroiditis seen in both hospitals were prepared, and the area under the curves (AUC), the cut-off points for discriminating Graves' disease from painless thyroiditis, the sensitivity, and the specificity were calculated. AUC and sensitivity of the FT(3)/FT(4) ratio were smaller than those of FT(3) and FT(4) in both hospitals. The patients treated at Ito hospital were then divided into 4 groups according to their FT4 levels (A: < or =2.3, B: >2.3 approximately < or =3.9, C: 3.9 approximately < or =5.4, D: >5.4 ng/dl), and the AUC, cut-off points, sensitivity, and specificity of the FT(3)/FT(4) ratios were calculated. The AUC and sensitivity of each group increased with the FT4 levels (AUC: 57.8%, 72.1%, 91.1%, and 93.4%, respectively; sensitivity: 62.6%, 50.0%, 77.8%, and 97.0%, respectively). The means +/- SE of the FT3/FT4 ratio in the Graves' disease groups were 3.1 +/- 0.22, 3.1 +/- 0.09, 3.2 +/- 0.06, and 3.1 +/- 0.07, respectively, versus 2.9 +/- 0.1, 2.6 +/- 0.07, 2.5 +/- 0.12, and 2.3 +/- 0.15, respectively, in the painless thyroiditis groups. In the painless thyroiditis patients, the difference in the FT3/FT4 ratio between group A and group D was significant (p<0.05). Thus, the FT3/FT4 ratio in patients with Graves' disease likely remains unchanged as the FT4 level rises, whereas this ratio decreases as the FT4 level rises in patients with painless thyroiditis. In conclusion, the FT3/FT4 ratios of patients with painless thyroiditis overlapped with those of patients with Graves' disease. However, this ratio was useful for differentiating between these two disorders when the FT4 values were high.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16284430     DOI: 10.1507/endocrj.52.537

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  20 in total

1.  Scintigraphic Profile of Thyrotoxicosis Patients and Correlation with Biochemical and Sonological Findings.

Authors:  Anil Kumar Avs; Abhish Mohan; P G Kumar; Pankaj Puri
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.

Authors:  Danae A Delivanis; Michael P Gustafson; Svetlana Bornschlegl; Michele M Merten; Lisa Kottschade; Sarah Withers; Allan B Dietz; Mabel Ryder
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

3.  Comparison of 99mTc Pertechnetate Thyroid Uptake Rates by Gamma Probe and Gamma Camera Methods for Differentiating Graves' Disease and Thyroiditis.

Authors:  Meihua Jin; Jonghwa Ahn; Seong-Gil Jo; Jangwon Park; Min Ji Jeon; Won Gu Kim; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2022-01-07

4.  Serum Free T3 to Free T4 Ratio as a Useful Indicator for Differentiating Destruction Induced Thyrotoxicosis from Graves' Disease.

Authors:  Suman Baral; Pradeep Krishna Shrestha; Vivek Pant
Journal:  J Clin Diagn Res       Date:  2017-07-01

5.  Predicting relapse of Graves' disease following treatment with antithyroid drugs.

Authors:  Lin Liu; Hongwen Lu; Yang Liu; Changshan Liu; Chu Xun
Journal:  Exp Ther Med       Date:  2016-02-09       Impact factor: 2.447

6.  Peak systolic velocity of superior thyroid artery for the differential diagnosis of thyrotoxicosis.

Authors:  Xiaolong Zhao; Lili Chen; Ling Li; Yao Wang; Yong Wang; Linuo Zhou; Fangfang Zeng; Yiming Li; Renming Hu; Hong Liu
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

7.  The ratio of serum free triiodothyronine to free thyroxine in children: a retrospective database survey of healthy short individuals and patients with severe thyroid hypoplasia or central hypothyroidism.

Authors:  Yuji Oto; Koji Muroya; Junko Hanakawa; Yumi Asakura; Masanori Adachi
Journal:  Thyroid Res       Date:  2015-07-08

8.  Pitting type of pretibial edema in a patient with silent thyroiditis successfully treated by angiotensin ii receptor blockade.

Authors:  Itsuro Kazama; Yoko Mori; Asuka Baba; Toshiyuki Nakajima
Journal:  Am J Case Rep       Date:  2014-03-14

9.  Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research.

Authors:  Johannes W Dietrich; Gabi Landgrafe-Mende; Evelin Wiora; Apostolos Chatzitomaris; Harald H Klein; John E M Midgley; Rudolf Hoermann
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-09       Impact factor: 5.555

10.  Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.

Authors:  Chutintorn Sriphrapradang; Adikan Bhasipol
Journal:  Ann Med Surg (Lond)       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.